These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31509485)

  • 1. Imaging endogenous synaptic proteins in primary neurons at single-cell resolution using CRISPR/Cas9.
    Matsuda T; Oinuma I
    Mol Biol Cell; 2019 Oct; 30(22):2838-2855. PubMed ID: 31509485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized CRISPR/Cas9-mediated in vivo genome engineering applicable to monitoring dynamics of endogenous proteins in the mouse neural tissues.
    Matsuda T; Oinuma I
    Sci Rep; 2019 Aug; 9(1):11309. PubMed ID: 31383899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ORANGE: A CRISPR/Cas9-based genome editing toolbox for epitope tagging of endogenous proteins in neurons.
    Willems J; de Jong APH; Scheefhals N; Mertens E; Catsburg LAE; Poorthuis RB; de Winter F; Verhaagen J; Meye FJ; MacGillavry HD
    PLoS Biol; 2020 Apr; 18(4):e3000665. PubMed ID: 32275651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 technology as a potent molecular tool for gene therapy.
    Karimian A; Azizian K; Parsian H; Rafieian S; Shafiei-Irannejad V; Kheyrollah M; Yousefi M; Majidinia M; Yousefi B
    J Cell Physiol; 2019 Aug; 234(8):12267-12277. PubMed ID: 30697727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-based genome engineering of zebrafish using a seamless integration strategy.
    Luo JJ; Bian WP; Liu Y; Huang HY; Yin Q; Yang XJ; Pei DS
    FASEB J; 2018 Sep; 32(9):5132-5142. PubMed ID: 29812974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S; Yamamoto T; Sakuma T
    Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
    Ahmad G; Amiji M
    Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas9-mediated generic protein tagging in mammalian cells.
    Thöne FMB; Kurrle NS; von Melchner H; Schnütgen F
    Methods; 2019 Jul; 164-165():59-66. PubMed ID: 30797903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Toolkit of CRISPR-Based Genome Editing Systems in Drosophila.
    Xu J; Ren X; Sun J; Wang X; Qiao HH; Xu BW; Liu LP; Ni JQ
    J Genet Genomics; 2015 Apr; 42(4):141-9. PubMed ID: 25953352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemistry and fluorescence imaging efficiently identify individual neurons with CRISPR/Cas9-mediated gene disruption in primary cortical cultures.
    Tsunematsu H; Uyeda A; Yamamoto N; Sugo N
    BMC Neurosci; 2017 Aug; 18(1):55. PubMed ID: 28764650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-cas System as a Genome Engineering Platform: Applications in Biomedicine and Biotechnology.
    Hashemi A
    Curr Gene Ther; 2018; 18(2):115-124. PubMed ID: 29473500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-mediated knock-in of an optimized TetO repeat for live cell imaging of endogenous loci.
    Tasan I; Sustackova G; Zhang L; Kim J; Sivaguru M; HamediRad M; Wang Y; Genova J; Ma J; Belmont AS; Zhao H
    Nucleic Acids Res; 2018 Sep; 46(17):e100. PubMed ID: 29912475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editing the Neuronal Genome: a CRISPR View of Chromatin Regulation in Neuronal Development, Function, and Plasticity.
    Yang MG; West AE
    Yale J Biol Med; 2016 Dec; 89(4):457-470. PubMed ID: 28018138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9 System: Opportunities and Concerns.
    Vasiliou SK; Diamandis EP; Church GM; Greely HT; Baylis F; Thompson C; Schmitt-Ulms G
    Clin Chem; 2016 Oct; 62(10):1304-11. PubMed ID: 27551006
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.